Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
Gjyrezi, Ada, Fang Xie, Olga Voznesensky, Prateek Khanna, Carla Calagua, Yang Bai, Justin Kung, et al. 2020. “Taxane Resistance in Prostate Cancer Is Mediated by Decreased Drug-Target Engagement.”. The Journal of Clinical Investigation 130 (6): 3287-98.